Autoinhibition: The cGAS enzyme has an autoinhibitory mechanism where specific domains within the protein interact with each other, preventing its activation. This conformational state keeps the enzyme in an inactive form until specific conditions trigger its release.
Binding to inhibitory proteins: Certain proteins, such as the inhibitory factor HERC6 (HECT and RLD domain-containing E3 ubiquitin ligase 6), can bind to cGAS and prevent its activation. HERC6 interacts with the cGAS enzyme and masks its catalytic site, thereby blocking its ability to synthesize cyclic GMP-AMP (cGAMP).
Subcellular localization: In resting cells, cGAS is predominantly localized in the cytoplasm, where it remains inactive. The presence of double-stranded DNA (dsDNA) in the cytoplasm, which can occur during cellular damage or infection, triggers the translocation of cGAS to the nucleus, where it encounters its DNA substrates and becomes activated.
Post-translational modifications: Post-translational modifications, such as phosphorylation and ubiquitination, can also affect the activity and localization of cGAS. Phosphorylation of cGAS by certain kinases can enhance its enzymatic activity, while ubiquitination can target cGAS for degradation, thereby limiting its availability.
These mechanisms collectively ensure that cGAS remains inactive under normal cellular conditions and is only activated upon sensing specific stimuli, such as the presence of cytosolic dsDNA, which is indicative of cellular stress or infection.
